Section of Gastroenterology, Department of Medicine, Lewis Katz School of Medicine at Temple University, 3401 North Broad Street, Philadelphia, PA, 19140, USA.
Department of General Surgery, Mayo Clinic, Jacksonville, FL, USA.
J Gastrointest Surg. 2020 Oct;24(10):2204-2211. doi: 10.1007/s11605-019-04391-x. Epub 2019 Sep 11.
Several surgical options exist for refractory gastroparesis (Gp) including gastric electric stimulation (GES) and pyloric surgery (PS) such as pyloromyotomy or pyloroplasty. Few studies exist comparing the outcomes of these surgeries.
Compare the clinical outcomes of GES, PS, and simultaneous GES+PS for refractory Gp.
Patients undergoing surgical intervention at our medical center from January 2016 to April 2019 were given pre- and post-surgery questionnaires to assess their response to intervention: Patient Assessment of Upper Gastrointestinal Symptoms (PAGI-SYM) grading symptoms and Clinical Patient Grading Assessment Scale (CPGAS) grading response to treatment. Results are expressed as mean ± SE.
One hundred thirty-two patients underwent surgical intervention; 12 were excluded. Mean CPGAS improvement overall was 2.8 ± 0.2 (p < 0.01): GES+PS had CPGAS score at 3.6 ± 0.5, pyloric interventions 3.1 ± 0.5, and GES 2.5 ± 0.4 (p > 0.05). Mean improvement in Gastroparesis Cardinal Symptom Index (GCSI) total score was 1.0 ± 0.1 (p < 0.01), with improvement of 1.1 ± 0.2 for GES + PS, 0.9 ± 0.2 for GES, and 0.9 ± 0.2 for PS (p > 0.05). GES and GES + PS, but not PS only, significantly improved symptoms of nausea and vomiting (p < 0.01). Among gastroparesis subtypes, patients with diabetic gastroparesis had more improvement on nausea/vomiting subscale compared with idiopathic gastroparesis (p = 0.028).
Patients with refractory symptoms of Gp undergoing GES, PS, or combined GES+PS each had significant improvement of their GCSI total score. GES and combined GES+PS significantly improved nausea/vomiting. These results suggest GES or combined GES+PS appears better for nausea/vomiting predominant refractory Gp.
胃轻瘫(Gp)的治疗方法有很多种,包括胃电刺激(GES)和幽门手术(PS),如幽门肌切开术或幽门成形术。比较这些手术结果的研究很少。
比较胃轻瘫难治性患者胃电刺激(GES)、PS 及同时行 GES+PS 的临床疗效。
2016 年 1 月至 2019 年 4 月在我院接受手术治疗的患者,在术前和术后均接受问卷调查,以评估其对干预的反应:上消化道症状患者评估量表(PAGI-SYM)分级症状和临床患者分级评估量表(CPGAS)分级治疗反应。结果表示为平均值±标准误差。
共 132 例患者接受了手术干预,其中 12 例被排除在外。总体而言,CPGAS 改善的平均值为 2.8±0.2(p<0.01):GES+PS 的 CPGAS 评分为 3.6±0.5,幽门干预为 3.1±0.5,GES 为 2.5±0.4(p>0.05)。胃轻瘫卡方症状指数(GCSI)总分的平均改善为 1.0±0.1(p<0.01),GES+PS 改善 1.1±0.2,GES 改善 0.9±0.2,PS 改善 0.9±0.2(p>0.05)。GES 和 GES+PS,但不是 PS,显著改善了恶心和呕吐的症状(p<0.01)。在胃轻瘫亚型中,糖尿病性胃轻瘫患者与特发性胃轻瘫相比,恶心/呕吐亚量表的改善更为明显(p=0.028)。
胃轻瘫难治性患者行 GES、PS 或 GES+PS 联合治疗,GCSI 总分均有显著改善。GES 和 GES+PS 显著改善恶心/呕吐。这些结果表明,GES 或 GES+PS 联合治疗可能更适合以恶心/呕吐为主的难治性胃轻瘫患者。